Genpharmasec edges higher on incorporating foreign subsidiary
Follow us Now on Telegram ! Get daily 10 - 12 important updates on Business, Finance and Investment. Join our Telegram Channel
Genpharmasec is currently trading at Rs. 3.27, up by 0.01 points or 0.31% from its previous closing of Rs. 3.26 on the BSE.
The scrip opened at Rs. 3.30 and has touched a high and low of Rs. 3.39 and Rs. 3.23 respectively. So far 263231 shares were traded on the counter.
The BSE group 'X' stock of face value Rs. 1 has touched a 52 week high of Rs. 5.77 on 17-Oct-2022 and a 52 week low of Rs. 2.68 on 29-Mar-2023.
Last one week high and low of the scrip stood at Rs. 3.56 and Rs. 3.10 respectively. The current market cap of the company is Rs. 92.47 crore.
The promoters holding in the company stood at 59.96%, while Non-Institutions held 40.04% stake in the company.
Genpharmasec has incorporated a foreign subsidiary namely ‘Genpharmasec Middle East DMCC’. The objects for which the company has been established are Medical, Surgical Equipment & Instruments Trading; Medical, Surgical Articles & Requisites Trading; Medical Gas Trading; Food Supplements Trading; Trading in Medicines (Outside UAE) (DMCC); and Trading in Pharmaceutical Products (Outside UAE) (DMCC).
Genpharmasec is an India-based company, which is engaged in pharmaceutical activities and trading in equity shares.
